Effect of angiotensin II on plasminogen activator inhibitor-1 production by cultured human mesangial cells

Nephron

Volumn 77, Issue 2, 1997, Pages 197-204

  Wilson, Heather M ^a   Haites, Neva E ^a   Booth, Nuala A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Angiotensin II; Mesangial cell; Plasminogen activator inhibitor 1

Indexed keywords

ANGIOTENSIN; FIBRONECTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL PROLIFERATION; DNA SYNTHESIS; EXTRACELLULAR MATRIX; GLOMERULOPATHY; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL;

EID: 0030870590     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190273     Document Type: Article

References (35)

1. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, cl al: Renal injur>' from angiotensin Il-niediaied hypertension, Hypertension 1992;19:464-474.
2. Kettler M, Noble NA, Border WA: Transforming growth factor-p and angiotensin II: The missing link from glomerular hyperfiltration to glomerulosclerosis? Annu Rev Physiol 1995; 57:279-295.
3. Wolf G: Vasoactive substances as regulators of renal growth, Exp Nephrol 1993;1:141-151.
4. Paul M, Wagner J, Dau VJ: Gene expression of the renin-angiotensin system in human tissues, Quantitative analysis by the polymerase chain reaction, J Clin Invest 1993:91:2058-2064.
5. Geisterfer AAT, Peach MJ, Owen GK: Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells, Circ Res 1988;62:749-756.
6. Kagami S, Border WA, Miller DA, Noble NA: Angiotensin 11 stimulates extracellular matrix protein synthesis through induction of TGF-ß expression in rat glomerular mesangial cells, J Clin Invest 1994;93:2431-2437.
7. Ling H, Vamvakas S, Schaefer L, Schnittler HJ, Schaefer RM, Heidland A: Angiotensin II induced cell hypertrophy: A potential role of impaired proteolytic activity in cultured LLC-PKI cells, Nephrol Dial Transplant 1995:10: 1305-1312.
8. Ridker PM, Gaboury CL, Conlin PR, Seely EW, Williams GH, Vaughan DE: Stimulation of PAI-I by in vivo infusion of angiotensin II, Circulation 1993;87:1969-1973.
9. Olson JA, Shiverick KT, Ogilvie S, Buhi WC, Raizada MK: Angiotensin II induces the secretion of PA1-1 and a tissue metalloproteinase inhibitor-related protein from rat brain astro-cvtes, Proc Natl Acad Sei USA 1991:88:1928-1932.
10. Vaughan DE, Lazos SA, Tong K: Angiotensin regulates the expression of PAI-I in cultured endothelial cells, A potential link between the renin-angiotensin system and thrombosis, J Clin Invest 1995;95:995-1001.
11. Fccner EP, Northrup JM, Aiello LP, King GL: Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells, J Clin Invest 1995;95:1353-1362.
12. Hamdan AD, Quisl WC, Gagne JB, Fcener EP: Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the ncointima of balloon-injured rat aorta, Circulation 1996;83:1076-1078.
13. Bell L, Madri JA: Influence of the angiotensin system on endothelial and smooth muscle cell migration, Am J Pathol 1990;137:7-12.
14. Dano K, Andreasen PA, Grundahl-Hansen J, Kristcnscn P, Neilscn LS, Skrivcr L: Plasminogen activators, tissue degradation and cancer, Adv Cancer Res 1985:44:135-266.
15. Wilson HM, Reid FJ, Brown PAJ, Power DA, Hailes NE, Booth NA: Effect of transforming growth factor ßl on plasminogen activators and plasminogen activator inhibitor-1 in renal glomerular cells, Exp Nephrol 1993:1:343-350.
16. Tomooka S, Border WA, Marshall BC, Noble NA: Glomerular matrix accumulation is linked to inhibition of the plasmin proteasc system, Kidney Int 1992:42:1462-1469.
17. Rondeau E, Mougenot B, Lacavc R, Peraldi MN, Kruitof EKO, Sracr JD: Plasminogen activator inhibitor 1 in renal fibrin deposits of human nephropathies, Clin Nephrol 1990:33: 55-60.
18. Stewart KN, Rov-Chaudhury P, Lumsden L, Jones MJ, Brown PAJ, Maclcod AM, Haites NE, Simpson JG, Power DA: Monoclonal antibodies to cultured human glomerular ntesan-gial cells, J Pathol 1991:163:265-272.
19. Cordell JL, Falini B, Erber WN: Immunoenzy-matic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP) complexes, J Histochem Cytochem 1984:32:219-229.
20. Wolf G, Habcrstroh N, cilson EG: Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells, Am J Pathol 1992:140:95-107.
21. Wilson HM, Haites NE, Reid FJ, Booth NA: Interleukin-113 up-regulatcs the plasminogen activator/plamin system in human mesangial cells, Kidney Int 1996:49:1097-1104.
22. MacGregor IR, Booth NA: An enzvme-linked immunosorbent assay (ELISA) used to study the cellular secretion of endothelial plasminogen activator inhibitor (PAI-1), Thromb Hac-niost 1988:59:68-72.
23. MacGregor IR, MacDonald S, Davies J, Mick-lem LR, James K: A monoclonal antibody enzyme linked immunosorbent assay (ELISA) directed towards a fibrin binding region of tissue-type plasminogen activator, Fibrinolysis 1987; 1:247-252.
24. Booth NA, Anderson JA, Bennett B, Platelets release protein which inhibit plasminogen activators, J Clin Pathol 1984:38:825-830
25. Andrcascn PA, Ricco A, Welinder KG, Douglas R, Sartorio R, Nielsen LS, Oppcnheimer C, Blasi F, Dano K: Plasminogen activator inhibitor type-1: Reactive center and amino terminal heterogeneity determined by protein and cDNA sequencing, FEBS Lett 1986:209: 213-218.
26. Sambrook J, Fritseh EF, Maniatis T: Molecular Cloning: A Laboratory' Manual, cd 2, Cold Spring Harbor Press, 1989, pp 6.3-7.84.
27. McKay NG, Hunter DJ, Haites NE, Power DA: Regulation of alternative splicing of the fibronectin II1CS domain by cytokines, Bio-chcm Biophvs Res Commun 1994:119:1005-1011.
28. Wolthius A, Bocs A, Rodemann P, Grand J: Vasoactive agents affect growth and protein synthesis of cultured rat mesangial cells, Kidney Int 1992:41:124-131.
29. Ray PE, Aguilera G, Kopp JB, Horikoshi S, Klotman PE: Angiotensin II receptor-mediated proliferation of cultured human fetal mesangial cells, Kidney Int 1991;40:764-771.
30. Anderson PW, Do YS, Hscuch WA: Angiotensin II causes mesangial cell hypertrophy, Hypertension 1993:21:29-35.
31. Naftilan AJ, Pratt RE, Dzau VJ: Induction of PDGF A-chain and c-mvc gene expression by angiotensin II in cultured rat vascular smooth muscle cells, J Clin Invest 1989:83:1419-1424.
32. Silver BJ, Jaffer FE, Abboud HE: Platelet derived growth factor synthesis in mesangial cells: Induction by multiple peptide mitogens, Proc Natl Acad Sci USA 1989:86:1056-1060.
33. Iwamoto T, Tamaki K, Nakayama M, Okuda S, Fu.ishima M: Effect of Endothclin I on fibrinolysis and plasminogen activator inhibitor I synthesis in rat mesangial cells, Nephron 1996; 73:273-279.
34. Mimuro J, Loskutof TDJ: Purification of a protein from bovine plasma that binds to type I plasminogen activator inhibitor and prevents its interaction with extracellular matrix, Evidence that the protein is vitronectin, J Biol Chcm 1989:264:936-939.
35. Ray PE, Bruggeman LA, Horikoshi S, Aguilera G, Klotman PE: Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to ATI receptors, Kidney int 1994:45:177-184.